Gafter U - Search Results

1

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial.

Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS. Boaz M, et al. Among authors: gafter u. Lancet. 2000 Oct 7;356(9237):1213-8. doi: 10.1016/s0140-6736(00)02783-5. Lancet. 2000. PMID: 11072938 Clinical Trial.

2

Baseline oxysterols and other markers of oxidative stress, inflammation and malnutrition in the vitamin e and intima media thickness progression in end-stage renal disease (VIPER) cohort.

Boaz M, Iuliano L, Himmelfarb J, Matas Z, Micheletta F, McMonagle E, Friedman V, Natoli S, Gvirtz G, Biro A, Smetana S, Sabo G, Gafter U, Weinstein T. Boaz M, et al. Among authors: gafter u. Nephron Clin Pract. 2005;100(4):c111-9. doi: 10.1159/000085290. Epub 2005 Apr 20. Nephron Clin Pract. 2005. PMID: 15849477 Clinical Trial.

3

Haemolysis in haemodialysis patients: evidence for impaired defence mechanisms against oxidative stress.

Weinstein T, Chagnac A, Korzets A, Boaz M, Ori Y, Herman M, Malachi T, Gafter U. Weinstein T, et al. Among authors: gafter u. Nephrol Dial Transplant. 2000 Jun;15(6):883-7. doi: 10.1093/ndt/15.6.883. Nephrol Dial Transplant. 2000. PMID: 10831646

4

Effect of sevelamer hydrochloride exposure on carotid intima media thickness in hemodialysis patients.

Boaz M, Katzir Z, Schwartz D, Gafter U, Biro A, Shtendik L, Kon V, Chernin G, Weinstein T. Boaz M, et al. Among authors: gafter u. Nephron Clin Pract. 2011;117(2):c83-8. doi: 10.1159/000319654. Epub 2010 Aug 6. Nephron Clin Pract. 2011. PMID: 20714166 Clinical Trial.

5

Erythrocytosis associated with renal artery thrombosis in a patient with polycystic kidney disease on hemodialysis.

Chagnac A, Zevin D, Weinstein T, Gafter U, Korzets A, Levi J. Chagnac A, et al. Among authors: gafter u. Acta Haematol. 1990;84(1):40-2. doi: 10.1159/000205025. Acta Haematol. 1990. PMID: 2117327

6

Improved immunogenicity of a novel third-generation recombinant hepatitis B vaccine in patients with end-stage renal disease.

Weinstein T, Chagnac A, Boaz M, Ori Y, Herman M, Zevin D, Schmilovitz-Weiss H, Gafter U. Weinstein T, et al. Among authors: gafter u. Nephron Clin Pract. 2004;97(2):c67-72. doi: 10.1159/000078403. Nephron Clin Pract. 2004. PMID: 15218332

7

Effects of erythropoietin on glucose tolerance in hemodialysis patients.

Chagnac A, Weinstein T, Zevin D, Korzets A, Hirsh J, Gafter U, Levi J. Chagnac A, et al. Among authors: gafter u. Clin Nephrol. 1994 Dec;42(6):398-400. Clin Nephrol. 1994. PMID: 7882604

8

Postoperative rhabdomyolysis in patients with end-stage renal failure.

Ori Y, Korzets A, Gruzman C, Chagnac A, Zevin D, Weinstein T, Herman M, Gafter U. Ori Y, et al. Among authors: gafter u. Am J Kidney Dis. 1998 Mar;31(3):539-44. doi: 10.1053/ajkd.1998.v31.pm9506695. Am J Kidney Dis. 1998. PMID: 9506695

9

Calcium balance during pulse alfacalcidol therapy for secondary hyperparathyroidism in CAPD patients treated with 1.0 and 1.25 mmol/L dialysate calcium.

Chagnac A, Ori Y, Weinstein T, Herman M, Korzets A, Zevin D, Hirsh J, Gafter U. Chagnac A, et al. Among authors: gafter u. Am J Kidney Dis. 1999 Jan;33(1):82-6. doi: 10.1016/s0272-6386(99)70261-1. Am J Kidney Dis. 1999. PMID: 9915271 Clinical Trial.

10

Successful intradialytic parenteral nutrition after abdominal "Catastrophes" in chronically hemodialysed patients.

Korzets A, Azoulay O, Chagnac A, Weinstein T, Avraham Z, Ori Y, Zevin D, Gafter U. Korzets A, et al. Among authors: gafter u. J Ren Nutr. 1999 Oct;9(4):206-13. doi: 10.1016/s1051-2276(99)90036-5. J Ren Nutr. 1999. PMID: 10528054

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters